Insights

Innovative Trial Focus ARENSIA specializes in early-phase clinical trials with novel compounds, offering a disruptive time and cost reduction for pharmaceutical and biotech companies seeking rapid proof-of-concept data.

Strategic Regional Presence With clinics positioned near major university and hospital hubs across Eastern Europe and the US, ARENSIA provides accessible patient populations and efficient recruitment, which can accelerate trial timelines for global partners.

Proven Cost Savings The company’s model reduces trial costs by up to 50 percent and shortens timelines by around 60 percent, appealing to organizations prioritizing budget efficiency and swift development phases.

Strong Industry Engagement ARENSIA’s collaborations with leading pharmaceutical firms, biotech companies, and participation in specialist webinars demonstrate a solid network that can be leveraged for new partnership opportunities.

Growth and Reputation High client retention with 93 percent repeat business suggests a trusted service provider, indicating that expanding offerings or partnership models could further attract global biotech and pharma clients seeking reliable early-phase trial solutions.

Similar companies to ARENSIA Exploratory Medicine GmbH

ARENSIA Exploratory Medicine GmbH Tech Stack

ARENSIA Exploratory Medicine GmbH uses 8 technology products and services including Microsoft 365, Font Awesome, JSON-LD, and more. Explore ARENSIA Exploratory Medicine GmbH's tech stack below.

  • Microsoft 365
    Email
  • Font Awesome
    Font Scripts
  • JSON-LD
    Javascript Frameworks
  • Google Charts
    Javascript Graphics
  • OWL Carousel
    Javascript Libraries
  • PWA
    Miscellaneous
  • PHP
    Programming Languages
  • Google Analytics
    Web Analytics

Media & News

ARENSIA Exploratory Medicine GmbH's Email Address Formats

ARENSIA Exploratory Medicine GmbH uses at least 1 format(s):
ARENSIA Exploratory Medicine GmbH Email FormatsExamplePercentage
First.Last@arensia-em.comJohn.Doe@arensia-em.com
46%
First.MiddleLast@arensia-em.comJohn.MichaelDoe@arensia-em.com
4%
First.Last@arensia-em.comJohn.Doe@arensia-em.com
46%
First.MiddleLast@arensia-em.comJohn.MichaelDoe@arensia-em.com
4%

Frequently Asked Questions

What is ARENSIA Exploratory Medicine GmbH's official website and social media links?

Minus sign iconPlus sign icon
ARENSIA Exploratory Medicine GmbH's official website is arensia-em.com and has social profiles on LinkedIn.

What is ARENSIA Exploratory Medicine GmbH's NAICS code?

Minus sign iconPlus sign icon
ARENSIA Exploratory Medicine GmbH's NAICS code is 5417 - Scientific Research and Development Services.

How many employees does ARENSIA Exploratory Medicine GmbH have currently?

Minus sign iconPlus sign icon
As of January 2026, ARENSIA Exploratory Medicine GmbH has approximately 252 employees across 2 continents, including EuropeNorth America. Key team members include Head Of Arensia Phase 1 Unit - Bucharest Oncology Institute: I. S.Founder And Ceo: C. H.Executive Director, Global Strategic Partnerships: L. S.. Explore ARENSIA Exploratory Medicine GmbH's employee directory with LeadIQ.

What industry does ARENSIA Exploratory Medicine GmbH belong to?

Minus sign iconPlus sign icon
ARENSIA Exploratory Medicine GmbH operates in the Research Services industry.

What technology does ARENSIA Exploratory Medicine GmbH use?

Minus sign iconPlus sign icon
ARENSIA Exploratory Medicine GmbH's tech stack includes Microsoft 365Font AwesomeJSON-LDGoogle ChartsOWL CarouselPWAPHPGoogle Analytics.

What is ARENSIA Exploratory Medicine GmbH's email format?

Minus sign iconPlus sign icon
ARENSIA Exploratory Medicine GmbH's email format typically follows the pattern of First.Last@arensia-em.com. Find more ARENSIA Exploratory Medicine GmbH email formats with LeadIQ.

When was ARENSIA Exploratory Medicine GmbH founded?

Minus sign iconPlus sign icon
ARENSIA Exploratory Medicine GmbH was founded in 2010.

ARENSIA Exploratory Medicine GmbH

Research ServicesNorth Rhine-westphalia, Germany201-500 Employees

ARENSIA is a German operator of professional research clinics, dedicated to performing early-phase clinical trials - Phase IB, IIA, and PROOF OF CONCEPT - with novel compounds. Our trials involve a wide range of patient populations.

ARENSIA clinics are designed to enable patient's access to innovative therapies early in the drug development process. Patients' safety and comfort are of paramount importance at ARENSIA.

Our facilities are strategically located within or adjacent to large university/private hospitals in the following cities: Phoenix, Arizona USA, Bucharest and Cluj-Napoca in Romania, Chisinau in Moldova, Tbilisi in Georgia, Kyiv in Ukraine and Sofia in Bulgaria. 

Due to its dedicated research-oriented infrastructure, ARENSIA achieves a time reduction of avg. 60% through unrivaled recruiting performance vs. typical clinical trial sites which are overcrowded by daily hospital duties, lack of staff, competition for the same populations, and long timelines for contract negotiations.

The shortened time and the different setup of concentrating effort on a few ARENSIA Clinics (instead of the traditional high number of sites) leads to an overall budget reduction of 50% for a typical Phase IB/IIA PROOF OF CONCEPT trial.

93% repeat business proves that ARENSIA’s value proposition is the long-expected disruptive breakthrough in time and cost! This has allowed our continuous growth while collaborating with the leading pharmaceutical companies worldwide, numerous biotechs, and global CROs.

Section iconCompany Overview

NAICS Code
5417 - Scientific Research and Development Services
Founded
2010
Employees
201-500

Section iconFunding & Financials

  • $10M$25M

    ARENSIA Exploratory Medicine GmbH's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $10M$25M

    ARENSIA Exploratory Medicine GmbH's revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.